Your browser doesn't support javascript.
loading
Mechanisms of Anticancer Drug Resistance in Hepatoblastoma.
Marin, Jose J G; Cives-Losada, Candela; Asensio, Maitane; Lozano, Elisa; Briz, Oscar; Macias, Rocio I R.
Afiliação
  • Marin JJG; Experimental Hepatology and Drug Targeting (HEVEFARM), University of Salamanca, IBSAL, 37007 Salamanca, Spain. jjgmarin@usal.es.
  • Cives-Losada C; Center for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carlos III National Institute of Health, 28029 Madrid, Spain. jjgmarin@usal.es.
  • Asensio M; Experimental Hepatology and Drug Targeting (HEVEFARM), University of Salamanca, IBSAL, 37007 Salamanca, Spain. candelacives@usal.es.
  • Lozano E; Experimental Hepatology and Drug Targeting (HEVEFARM), University of Salamanca, IBSAL, 37007 Salamanca, Spain. masensio002@usal.es.
  • Briz O; Experimental Hepatology and Drug Targeting (HEVEFARM), University of Salamanca, IBSAL, 37007 Salamanca, Spain. elisa_biologia@usal.es.
  • Macias RIR; Center for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carlos III National Institute of Health, 28029 Madrid, Spain. elisa_biologia@usal.es.
Cancers (Basel) ; 11(3)2019 Mar 22.
Article em En | MEDLINE | ID: mdl-30909445
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2019 Tipo de documento: Article